CompanyDrug

Doer Bio and MSD Collaborate on Clinical Trial for Anti-Claudin18.2 Antibody DR30303

CompanyPolicy / Regulatory

WuXi Biologics’ Shanghai Subsidiary Removed from US UVL

Policy / Regulatory

Liaoning Publishes Fourth Round of Volume-Based Procurement Winning Bids

CompanyDeals

Cryofocus Medtech Set for IPO on Hong Kong Stock Exchange

CompanyMedical Device

NMPA Approves SonoScape and Acoustic Life’s Intravascular Ultrasound Products

CompanyDrug

Boehringer Ingelheim’s Spevigo Approved by NMPA for Generalized Pustular Psoriasis

Drug

Cosmo Pharmaceuticals’ Lumeblue Completes Phase III Trial in China

CompanyMedical Device

Acotec Scientific’s NEO-Skater Balloon Approved by NMPA for Intracranial Vessels

CompanyDrug

Tracon Pharmaceuticals Provides Positive Update on Envafolimab Phase II Trial

CompanyDrug

Sirnaomics Announces Interim Results for STP705 in Phase IIb Study for isSCC

CompanyDrug

Henlius Biotech Initiates Phase I Trial for HLX60 in Australia

CompanyDeals

China Meheco to Import and Distribute Pfizer’s Paxlovid in Mainland China